Ravi Majeti MD, PhD is the Virginia and D.K. Ludwig Professor, Professor of Medicine (Hematology), and Director of the Institute for Stem Cell Biology and Regenerative Medicine at the Stanford University School of Medicine. He was an undergraduate at Harvard, earned his MD and PhD from UCSF, trained in Internal Medicine at Brigham and Women’s Hospital in Boston, and completed his Hematology Fellowship at Stanford. While at Stanford, he completed post-doctoral training in the laboratory of Irving Weissman, where he investigated acute myeloid leukemia (AML) stem cells.

Dr. Majeti directs an active NIH-funded laboratory that focuses on the molecular characterization and therapeutic targeting of leukemia stem cells in human hematologic disorders, particularly AML, and has published >120 peer-reviewed articles. He is a recipient of the Burroughs Wellcome Career Award for Medical Scientists, the New York Stem Cell Foundation Robertson Investigator Award, the Leukemia and Lymphoma Society Scholar Award, the Clifford Prize, and the McCulloch and Till Award from the International Society for Experimental Hematology.